A bill to direct the National Institute of Arthritis, Metabolism, and Digestive Diseases to conduct such studies as may be necessary to determine the safety and efficacy under section 505 of the Federal Food, Drug, and Cosmetic Act of dimethylsulfoxide (DMSO) as a topical analgesic and to provide that, if the drug is so determined to be safe and effective, new drug applications may be approved under such section based on the evidence submitted by the Institute.

[AI summary unavailable — showing source text] Requires the Director of the National Institute of Arthritis, Metabolism, and Digestive Diseases to conduct such studies as are necessary to determine the safety and efficacy of dimethyl sulfoxide as a topical analgesic. Requires the submission and approval by the Secretary of Health and Human Services of a new drug application should such investigations prove the safety and efficacy of such substance for its intended use.…